Document: Questions and answers on Implementing Regulation (EU) 2025/1466: Amendment of Regulation (EU) No 520/2012 and Conclusion of the Signal Detection in EudraVigilance Pilot by marketing authorisation holders-2026/1/28

国家药监局关于发布仿制药参比制剂目录（第一百零二批）及调出参比制剂目录品种清单（第四批）的通告（2026年第7号）-2026/3/9

Document: CHMP PROM minutes for the meeting on 10 June 2025-2026/4/7

关于公开征求《<慢性乙型肝炎病毒感染治疗药物临床试验技术指导原则>问答文件（征求意见稿）》意见的通知-2026/7/6

Document: Annex 1 - Qualification opinion briefing book for the Big MS Data network registries on Post Authorization Safety Studies-2026/8/12

中药新药用于慢性胃炎的临床疗效评价技术指导原则（试行）-2022/12/21

关于公开征求《抗肿瘤药物说明书安全性信息撰写技术指导原则（征求意见稿）》意见的通知-2023/6/30

Development and manufacture of human medicinal products specifically designed for phage therapy - Scientific guideline-2023/12/22

Document: Product Management Service (PMS) roadmap-2025/1/24

Document: Minutes of the CAT meeting 22-24 January 2025-2025/2/27